GPT and metabolic dysfunction-associated steatohepatitis: Clinical signs suggestive of increased risk to develop fibrosis in children with NASH may include higher ALT (>80 U/L), splenomegaly, and AST/ALT >1, while panhypopituitarism and T2DM are accepted clinical risk factors for NASH and advanced fibrosis (2).